Preferred Label : daridorexant;

MeSH synonym : nemorexant; methanone, ((2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl)(5-methoxy-2-(2H-1,2,3-traizol-2-yl)phenyl)-; ((S)-(2-(5-chloro-4-methyl-1H-benzo(d)imidazol-2-yl)-2-methylpyrrolidin-1-yl) (5 methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone);

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3443615/fr/quviviq-daridorexant-insomnie-chronique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
administration, oral
daridorexant
evaluation of the transparency committee
daridorexant
chronic insomnia
sleep initiation and maintenance disorders

---
https://www.ema.europa.eu/en/medicines/human/EPAR/quviviq
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
daridorexant
daridorexant
adult
sleep initiation and maintenance disorders
drug approval
europe
administration, oral
Dual Orexin Receptor Antagonists
Dual Orexin Receptor Antagonists
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
daridorexant

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.